Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Bergentoft Pharma Consulting AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 4 More Arrow 1,333 More Arrow 1,373
Financial expenses 10 Less Arrow 5 Less Arrow 0
Earnings before taxes -51 More Arrow 1,165 Less Arrow 846
EBITDA -105 More Arrow 1,154 Less Arrow 846
Total assets 2,061 More Arrow 2,673 Less Arrow 1,963
Current assets 1,340 More Arrow 2,031 Less Arrow 1,295
Current liabilities 68 More Arrow 420 More Arrow 512
Equity capital 1,835 More Arrow 2,084 Less Arrow 1,348
- share capital 32 More Arrow 34 Less Arrow 33
Employees (average) 1 More Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 89.0% Less Arrow 78.0% Less Arrow 68.7%
Turnover per employee 4 More Arrow 666 More Arrow 1,373
Profit as a percentage of turnover -1275.0% More Arrow 87.4% Less Arrow 61.6%
Return on assets (ROA) -2.0% More Arrow 43.8% Less Arrow 43.1%
Current ratio 1970.6% Less Arrow 483.6% Less Arrow 252.9%
Return on equity (ROE) -2.8% More Arrow 55.9% More Arrow 62.8%
Change turnover -1,285 More Arrow -47 More Arrow 587
Change turnover % -100% More Arrow -3% More Arrow 75%
Chg. No. of employees -1 More Arrow 1 Less Arrow 0
Chg. No. of employees % -50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.